chrisvoncsefalvay/vaers-outcomes huggingface dataset:
High fever over 104 for 48hrs.; Severe body ache; Chills; Fatigue; Blurry vision; Nausea; Headache; Stomach cramps; This is a spontaneous report from a contactable other hcp (patient). A 37-year-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on 22Oct2021 12:30 at 37-year-old (Batch/Lot number was not reported) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunization. Medical history included Sinusitis, Known allergies: Sulfa and Antibiotics. The patient previously took first dose of BNT162B2 on 30Jan2021 at 37-year-old (Location of injection: Arm Left, Vaccine Administration Time: 12:00 PM) for COVID-19 immunization; second dose of BNT162B2 on 20Feb2021 at 37-year-old (Location of injection: Arm Left, Vaccine Administration Time: 09:00 AM) for COVID-19 immunization. Patient was not pregnant at time of vaccination. Facility where the most recent COVID-19 vaccine was administered: Doctor's office/urgent care. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient's concomitant medications were not reported. The patient experienced high fever over 104 for 48hrs on 22Oct2021 21:00 with outcome of recovered in 2021, severe body ache on 22Oct2021 21:00 with outcome of recovering, chills on 22Oct2021 21:00 with outcome of recovering, fatigue on 22Oct2021 21:00 with outcome of recovering, blurry vision on 22Oct2021 21:00 with outcome of recovering, nausea on 22Oct2021 21:00 with outcome of recovering, headache on 22Oct2021 21:00 with outcome of recovering, stomach cramps on 22Oct2021 21:00 with outcome of recovering. No treatment given. Case was reported as non-serious.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Upper arm/deltoid 6 x 4 cm area of redness, warm to touch, swelling & painful.
had anaphylaxis after receiving prevnar and infanrix. suspect infanrix as cause (because of left sided hives on leg and bovine protein in vax). swelling and hives at injection site on left leg. asthma-like coughing, runny nose. fever of 102.  diarrhea 48 hours past injection.  treatment was triminic thin strips every 6 hours for 4 days - prednisone for 3 days and silapap elixir. not recovered yet.  1/12/09 MR received from PCP. Pt in for WCC and imms 12/27/08. That pm developed swelling and urticaria around injection site as well as fever, cough and runny nose.  PE (+) for tachypnea at 40/min. Tx with albuterol with no effect on tachypnea, as well as prednisone and diphenhydramine. Epipen as needed.  Follow-up: Patient has significant beef allergy.
warm arm; an off-colored dark pink circle the size of a nickel that was not sore/Pink/Off-coloured arm; red arm; swollen 2 inches in diameter; red spot; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red spot), ERYTHEMA (red arm), SWELLING (swollen 2 inches in diameter), FEELING HOT (warm arm) and SKIN DISCOLOURATION (an off-colored dark pink circle the size of a nickel that was not sore/Pink/Off-coloured arm) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced ERYTHEMA (red spot). On 23-Feb-2021, the patient experienced ERYTHEMA (red arm) and SWELLING (swollen 2 inches in diameter). On an unknown date, the patient experienced FEELING HOT (warm arm) and SKIN DISCOLOURATION (an off-colored dark pink circle the size of a nickel that was not sore/Pink/Off-coloured arm). On 13-Feb-2021, ERYTHEMA (red spot) outcome was unknown. At the time of the report, ERYTHEMA (red arm), SWELLING (swollen 2 inches in diameter), FEELING HOT (warm arm) and SKIN DISCOLOURATION (an off-colored dark pink circle the size of a nickel that was not sore/Pink/Off-coloured arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and treatment information were not provided.
I have had dizziness, fatigue and a headache since receiving the booster that hasn?t gone away. It?s going on almost 4 weeks now.  I have tried pain relievers such as Tylenol, Advil, etc. but nothing has helped.
Information has been received from a licensed practical nurse (L.P.N.) concerning a 5-year-old female, with no pertinent medical history and allergies, who on 14-JUN-2007 was vaccinated in the right thigh with a 0.5 milliliter dose of PROQUAD (lot# 657300/0545U). Concomitant therapy included IPV (unspecified), DTaP (unspecified) and VAQTA in different injection sites. On 15-JUN-2007 the patient experienced a 2 centimeter x 4 centimeter lesion on the right thigh at the injection site. She was treated with AUGMENTIN ES. The following day on 16-Jun-2007 she was worse and was hospitalized with cellulitis at the injection site. She was treated with intravenous antibiotics, nafcilin sodium and ceftoaxime sodium. Laboratory studies included a negative blood culture on 16-Jun-2007. The patient was discharged from the hospital on 19-Jun-2007. It was reported that on 13-Dec-2002 the patient initially received a dose of MMR II and on 25-Mar-2003 received a dose of VARIVAX and had no adverse reactions. No product quality complaint was involved. The reporter considered the patient's cellulitis to be an other important medical event. Additional information has been requested.
pt devel fever of 101 1 day following vax; subsided w/in 24-48 hrs;
Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium
2/23/21- Redness swelling to Rt side of face - Rt eye red and swollen and headache Rt entire arm swollen and redness from shoulder to elbow w/a sting 2 weeks after 2nd dose
swollen lymph node under her arm; Pain; This is a spontaneous report from a contactable consumer (patient). A 23-years-old female patient received second dose of bnt162b2 (COVID-19 Vaccine, lot# EL1283), via an unspecified route of administration on 08Jan2021 at single dose on right arm for covid-19 immunisation. Medical history was none. There were no concomitant medications. The patient previously received first dose of COVID-19 Vaccine for COVID-19 immunisation on 18Dec2020. On 09Jan2021, she noticed she had a swollen lymph node under her arm that hadn't gone away. It had gotten more swollen and had spread. The pain had gotten more intense. The pain started as an ache then it was sharp and was now painful to touch. Both conditions were reported as worsen. The event outcome was not recovered.
Patient said they had a large red welt that covered the arm, was very itchy and swollen. Has gone down in size the next day but still itchy. Has had both of these vaccines before with no previous reactions. Recommended for her to apply cold compress to swollen area, could taken BENADRYL for itching.
patients BP went way down.  had emt come out to evaluate.  did not need to be transported to hosp
tested positive for COVID-19; lost sense of taste; red face; warm, hot, red face; flu-like symptoms; chills; achiness; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red face), FEELING HOT (warm, hot, red face), INFLUENZA LIKE ILLNESS (flu-like symptoms), CHILLS (chills) and PAIN (achiness) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Lupus erythematosus.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Dec-2020, the patient experienced ERYTHEMA (red face). 31-Dec-2020, the patient experienced FEELING HOT (warm, hot, red face), INFLUENZA LIKE ILLNESS (flu-like symptoms), CHILLS (chills), PAIN (achiness) and FATIGUE (fatigue). On 06-Jan-2021, the patient experienced AGEUSIA (lost sense of taste). On 07-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for COVID-19). On 05-Jan-2021, ERYTHEMA (red face), FEELING HOT (warm, hot, red face), INFLUENZA LIKE ILLNESS (flu-like symptoms), CHILLS (chills), PAIN (achiness) and FATIGUE (fatigue) had resolved. At the time of the report, AGEUSIA (lost sense of taste) and SARS-COV-2 TEST POSITIVE (tested positive for COVID-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatments of these events are unknown.  Very limited information regarding these events has been provided at this time. The patient probably experienced asymptomatic COVID-19 infection before being administered with the mRNA-1273 vaccine; Reporter's Comments: Very limited information regarding these events has been provided at this time. The patient probably experienced asymptomatic COVID-19 infection before being administered with the mRNA-1273 vaccine
pt states arm muscle soreness ongoing since the immunization. Sought evaluation by physician and imaging but no abnormality was found.
convuls 2-3 days p/vax;MRI CT normal but has uncontrolled sz;sz disorder
Local reaction to vaccine (LT) 12x14 mm induration; mild erythema
Pain; This case was reported by a pharmacist via call center representative and described the occurrence of pain in a 68-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but could be 67 or 68 years. The reporter stated that the patient experienced pain after vaccination. The reporter consented to follow up. For tolerance to 2nd dose refer linked case US2019234370, reported by the same reporter.
Day of vaccine, I felt like my lymph nodes were swollen. Two days later the injection site started to get deep red. Friday I started to about an inch of so, swell up some. Saturday I had a rash on my arm by the injection site, the top part on my bicep was pretty red and swollen. I didn't take my Humara or Zolar injection. On Sunday the rash got worse and grew in size and really hot to touch, the pain was radiating all the way to my wrist and hurt really bad causing pain when I moved my wrist. It was hard for me to go to sleep so I called the dr and went in . The dr. said it looked less red that what it was and told me to take Ibuprofen 800mg* 3x day.  The pain is now in both wrist and hard for to grip stuff and a little hot to touch.  You can see the difference in the skin tone where the rash was, it looks bruised.
A report has been received from a physician concerning a 7 year old, female subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on an unknown date. It was reported that the patient was administered expired FLUMIST QUADRIVALENT on 08-Sep-2014. The outcome of the event of administered expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
Loss sense of smell; Changed his apatite for meat (he cant eat meat or even look at it); Very thirsty; Terrible headache; Fatigue; Low grade fever 100.4 was highest with burning in the eyes; Low grade fever 100.4 was highest with burning in the eyes; This spontaneous case was reported by a consumer and describes the occurrence of EYE IRRITATION (Low grade fever 100.4 was highest with burning in the eyes), ANOSMIA (Loss sense of smell), DECREASED APPETITE (Changed his apatite for meat (he cant eat meat or even look at it)), THIRST (Very thirsty) and HEADACHE (Terrible headache) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced EYE IRRITATION (Low grade fever 100.4 was highest with burning in the eyes), DECREASED APPETITE (Changed his apatite for meat (he cant eat meat or even look at it)), THIRST (Very thirsty), HEADACHE (Terrible headache), FATIGUE (Fatigue) and PYREXIA (Low grade fever 100.4 was highest with burning in the eyes). On 26-Mar-2021, the patient experienced ANOSMIA (Loss sense of smell). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 30-Mar-2021, HEADACHE (Terrible headache) and FATIGUE (Fatigue) had resolved. On 15-May-2021, EYE IRRITATION (Low grade fever 100.4 was highest with burning in the eyes), ANOSMIA (Loss sense of smell), DECREASED APPETITE (Changed his apatite for meat (he cant eat meat or even look at it)), THIRST (Very thirsty) and PYREXIA (Low grade fever 100.4 was highest with burning in the eyes) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-May-2021: Follow up information received on 15-May-2021 contained updated event outcomes.
Temp elevated to 103 the first 24 hrs past receiving the vax; The following AM temp elevated to 105 9OCT91 pt seen by MD mom told pt had rt ear infect; temp dropped p/beginning of amoxicillin;
fever that is "on and off"; headache that is "on and off"; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever that is "on and off") and HEADACHE (headache that is "on and off") in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced PYREXIA (fever that is "on and off") and HEADACHE (headache that is "on and off"). At the time of the report, PYREXIA (fever that is "on and off") and HEADACHE (headache that is "on and off") outcome was unknown. Not Provided          Treatment Motrin   This case was linked to US-MODERNATX, INC.-MOD-2021-076161 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-076161:first dose
A nurse reported that a patient received an injection of Pnu-Imune 23. Subsequently, the patient  developed an injection site reaction characterized by redness and swelling which extended from the elbow to middle of the lower arm. The reporter indicated that this was a "booster shot" with the previous injection given >5 years ago. No further info was available at the date of this report. MANUFACTURER'S COMMENT: The reporter indicated that 3 patients experienced this event; however, they are not presently identifiable. Additional reports will be generated when identifying info is provided.
Fever 104 (ax) in afternoon after AM vaccination. (Temp was 99.1 (ax) before shot at home and 97.1 in office.)
same day vax given pt slept in truck overnoc & went fishing all day the following day; pt noted numbness upper posterior arm & pinching sensation to elbow; pt stated had associated pain @ sites also; seen by MD tx by chiropractor w/heat;
Patient complaining of pain in her left arm and changes in vision.  No fever, body aches, nausea, vomiting, dizziness, or chills.  She states the night she got the Covid-19 booster (10/29/2021) when she woke up she was having double vision.  She had no headache, and doesn't have a history of vision problems from headaches.  This lasted through the night but was gone the next day.  These symptoms have not come back.  She thinks this is related to the vaccine and not her other medical conditions.
This spontaneous case reported by a consumer, describes the occurrence of extreme fatigue, aches, pyrexia (temperature of 102), dyspnea (shortness of breath) and pain(s) in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 036A21A) for COVID-19 immunization. No medical history reported. On Apr 9, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced extreme fatigue, aches, pyrexia (temperature of 102), dyspnea (shortness of breath) and pain(s). At the time of the report, extreme fatigue, aches, pyrexia (temperature of 102), dyspnea (shortness of breath) and pain(s) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown.
Patient was ordered to receive the Pfizer-BioNTech Bivalent Booster vaccine during their hospitalization. Bivalent vaccines were prepared in batch, however a monovalent vial was erroneously used and thus the prepared vaccines were monovalent but labelled as bivalent. Monovalent vaccine was subsequently dispensed and administered to patient when patient was ordered for bivalent vaccine.
Initial report received on 07 November 2008 from a nurse. A 58-year-old male patient with no concurrent illnesses and "unknown" past medical history, had received an intramuscular left deltoid injection of Fluzone SV 2008-2009 (lot number U2761AA) on 06 November 2009 at 11:30am. Approximate four and a half hours post-vaccination, around 16:00 pm, the patient's eyelids were swollen , the sclera in his eyes were reddened, his neck was swelling. The patient had body aches and had developed a cough, and his voice was hoarse. The patient was treated with Benadryl by the nurse and was subsequently examined by a physician. Results of that examination were not provided. It was not reported whether any diagnostic tests or laboratory data were performed. At the time of this report, it was "unknown" if the patient had recovered. Follow up information was received on 09 February 2009 from a health care professional. The patient recovered. The date of recovery was not provided. Follow up information received 09 March 2009 from a health care professional. There had been no laboratory or diagnostic tests performed and the patient had no sick exposures; however the patient was also a health care professional. The patient self medicated with Benadryl x2 which began to reverse the symptoms. According to the reporter, the patient had not experienced any difficulty breathing and they had completely recovered on the same day of vaccination. Follow up information was received 27 March 2009 from a health care professional. The patient was an anesthesiologist who self medicated with Benadryl to treat the event, and he had not had a doctor's visit (previously reported as having been examined by a physician). A diagnosis had not been determined for the event and no additional information was provided.
26th January 2021-after the injection-she became foggy funny headed for about an hour-her words 27th January 2021-Chills, nauseated 28th January 2021-Body aches, left deltoid area extra tender, nauseated, HA, she has a history of migraines 29th January 2921-A lot better today she took Tylenol for her symptoms-told to go to the ER if her symptoms get worse, PCM if she needs to
pt recv vax 2APR98 & 9APR98 pt devel canker sores in mouth & on upper lip p/pt had braces readjusted 3 days prior to onset;
Tested positive for COVID-19; Lack of drug effect; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (Tested positive for COVID-19) and DRUG INEFFECTIVE (Lack of drug effect) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergy to drug Percocet.), Latex allergy, Rubber sensitivity and Fruit allergy.   On 31-Dec-2020 at 10:11 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 28-Jan-2021 at 10:20 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 27-Dec-2021, the patient experienced COVID-19 (Tested positive for COVID-19) and DRUG INEFFECTIVE (Lack of drug effect). At the time of the report, COVID-19 (Tested positive for COVID-19) and DRUG INEFFECTIVE (Lack of drug effect) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Dec-2021, SARS-CoV-2 test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient had no chronic or long-standing health conditions. The patient did not have any acute illness at the time of vaccination and up to one month before.  Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.  Company comment: This spontaneous case concerns a 34 year old female patient with no relevant medical history reported, who experienced the unexpected non serious AESI of COVID 19, approximately 11 months after receiving the second dose of mRNA-1273 vaccine. Additionally, Drug ineffective was reported. The interval between the 2 doses was approximately 28 days. The patient tested positive for COVID 19. The benefit-risk relationship of mRNA-1273 is not affected by this report.   This case was linked to MOD-2022-504317 (Patient Link).; Sender's Comments: This spontaneous case concerns a 34 year old female patient with no relevant medical history reported, who experienced the unexpected non serious AESI of COVID 19, approximately 11 months after receiving the second dose of mRNA-1273 vaccine. Additionally, Drug ineffective was reported. The interval between the 2 doses was approximately 28 days. The patient tested positive for COVID 19. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Arm became painful, red, hot, swollen and then a dime sized blister formed, then popped, then reformed. Duration total 4 - 5 days.